{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:30:39Z","timestamp":1792672239550,"version":"4.5.0"},"reference-count":38,"publisher":"European Respiratory Society (ERS)","issue":"168","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2023,3,15]]},"published-print":{"date-parts":[[2023,6,30]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>The World Health Organization (WHO) recommends that outpatient people living with HIV (PLHIV) undergo tuberculosis screening with the WHO four-symptom screen (W4SS) or C-reactive protein (CRP) (5\u2005mg\u00b7L<jats:sup>\u22121<\/jats:sup>cut-off) followed by confirmatory testing if screen positive. We conducted an individual participant data meta-analysis to determine the performance of WHO-recommended screening tools and two newly developed clinical prediction models (CPMs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Following a systematic review, we identified studies that recruited adult outpatient PLHIV irrespective of tuberculosis signs and symptoms or with a positive W4SS, evaluated CRP and collected sputum for culture. We used logistic regression to develop an extended CPM (which included CRP and other predictors) and a CRP-only CPM. We used internal\u2013external cross-validation to evaluate performance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>We pooled data from eight cohorts (n=4315 participants). The extended CPM had excellent discrimination (C-statistic 0.81); the CRP-only CPM had similar discrimination. The C-statistics for WHO-recommended tools were lower. Both CPMs had equivalent or higher net benefit compared with the WHO-recommended tools. Compared with both CPMs, CRP (5\u2005mg\u00b7L<jats:sup>\u22121<\/jats:sup>cut-off) had equivalent net benefit across a clinically useful range of threshold probabilities, while the W4SS had a lower net benefit. The W4SS would capture 91% of tuberculosis cases and require confirmatory testing for 78% of participants. CRP (5\u2005mg\u00b7L<jats:sup>\u22121<\/jats:sup>cut-off), the extended CPM (4.2% threshold) and the CRP-only CPM (3.6% threshold) would capture similar percentages of cases but reduce confirmatory tests required by 24, 27 and 36%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>CRP sets the standard for tuberculosis screening among outpatient PLHIV. The choice between using CRP at 5\u2005mg\u00b7L<jats:sup>\u22121<\/jats:sup>cut-off or in a CPM depends on available resources.<\/jats:p><\/jats:sec>","DOI":"10.1183\/16000617.0021-2023","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T08:31:08Z","timestamp":1686126668000},"page":"230021","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis"],"prefix":"10.1183","volume":"32","author":[{"given":"Ashar","family":"Dhana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6257-1285","authenticated-orcid":false,"given":"Rishi K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-4267","authenticated-orcid":false,"given":"Yohhei","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre P.","family":"Kengne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5023-6658","authenticated-orcid":false,"given":"Andrew D.","family":"Kerkhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya","family":"Cattamanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron W.P.","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9216-2415","authenticated-orcid":false,"given":"Grant","family":"Theron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gcobisa","family":"Ndlangalavu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4276-7117","authenticated-orcid":false,"given":"Robin","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9569-4097","authenticated-orcid":false,"given":"Paul K.","family":"Drain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire J.","family":"Calderwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdad","family":"Noursadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Boyles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"2024102404131153000_32.168.230021.1","unstructured":"World Health Organization . Global tuberculosis report 2022. Geneva, World Health Organization, 2022."},{"key":"2024102404131153000_32.168.230021.2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000802"},{"key":"2024102404131153000_32.168.230021.3","unstructured":"World Health Organization. High priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting, 28\u201329 April 2014, Geneva, Switzerland. Geneva, World Health Organization, 2014."},{"key":"2024102404131153000_32.168.230021.4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000391"},{"key":"2024102404131153000_32.168.230021.5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(21)00387-X","article-title":"Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis","volume":"22","author":"Dhana","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2024102404131153000_32.168.230021.6","unstructured":"World Health Organization . WHO consolidated guidelines on tuberculosis: module 2: screening: systematic screening for tuberculosis disease. Geneva, World Health Organization, 2021. Report No.: 9240022678."},{"key":"2024102404131153000_32.168.230021.7","unstructured":"World Health Organization . Rapid communication on systematic screening for tuberculosis. Geneva, World Health Organization, 2020. Report No.: 9240016554."},{"key":"2024102404131153000_32.168.230021.8","doi-asserted-by":"crossref","first-page":"e1003739","DOI":"10.1371\/journal.pmed.1003739","article-title":"Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: a cohort study","volume":"18","author":"Auld","year":"2021","journal-title":"PLoS Med"},{"key":"2024102404131153000_32.168.230021.9","doi-asserted-by":"crossref","first-page":"e0181519","DOI":"10.1371\/journal.pone.0181519","article-title":"A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa","volume":"12","author":"Hanifa","year":"2017","journal-title":"PLoS One"},{"key":"2024102404131153000_32.168.230021.10","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu095"},{"key":"2024102404131153000_32.168.230021.11","doi-asserted-by":"crossref","first-page":"e1003420","DOI":"10.1371\/journal.pmed.1003420","article-title":"A clinical score for identifying active tuberculosis while awaiting microbiological results: development and validation of a multivariable prediction model in sub-Saharan Africa","volume":"17","author":"Baik","year":"2020","journal-title":"PLoS Med"},{"key":"2024102404131153000_32.168.230021.12","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.ijid.2020.03.012","article-title":"A clinical score has utility in tuberculosis case-finding among patients with HIV: a feasibility study from Bissau","volume":"92S","author":"Aunsborg","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2024102404131153000_32.168.230021.13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis775"},{"key":"2024102404131153000_32.168.230021.14","first-page":"867","article-title":"Screening scheme development for active TB prediction among HIV-infected patients","volume":"42","author":"Nanta","year":"2011","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2024102404131153000_32.168.230021.15","doi-asserted-by":"crossref","first-page":"ofz543","DOI":"10.1093\/ofid\/ofz543","article-title":"A clinical prediction score including trial of antibiotics and C-reactive protein to improve the diagnosis of tuberculosis in ambulatory people with HIV","volume":"7","author":"Boyles","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2024102404131153000_32.168.230021.16","doi-asserted-by":"publisher","DOI":"10.7326\/L15-5093"},{"key":"2024102404131153000_32.168.230021.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.3656"},{"key":"2024102404131153000_32.168.230021.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001886"},{"key":"2024102404131153000_32.168.230021.19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-3"},{"key":"2024102404131153000_32.168.230021.20","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5732"},{"key":"2024102404131153000_32.168.230021.21","doi-asserted-by":"crossref","first-page":"636","DOI":"10.5588\/ijtld.12.0811","article-title":"Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis","volume":"17","author":"Lawn","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102404131153000_32.168.230021.22","unstructured":"Reeve B , Ndlangalavu G , Palmer Z , et al. Accuracy of Xpert Ultra and Xpert MTB\/RIF in people living with HIV initiating antiretroviral treatment who have minimal TB symptoms. 50th World Conference on Lung Health of the International Union against Tuberculosis and Lung Disease, Hyderabad, India, Oct 30\u2013Nov 2, 2019; p. S115."},{"key":"2024102404131153000_32.168.230021.23","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/QAD.0000000000001902","article-title":"C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa.","volume":"32","author":"Shapiro","year":"2018","journal-title":"AIDS"},{"key":"2024102404131153000_32.168.230021.24","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30488-7"},{"key":"2024102404131153000_32.168.230021.25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jinf.2022.10.041","article-title":"Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults","volume":"86","author":"Calderwood","year":"2023","journal-title":"J Infection"},{"key":"2024102404131153000_32.168.230021.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441"},{"key":"2024102404131153000_32.168.230021.27","unstructured":"Rubin DB . Multiple Imputation for Nonresponse in Surveys. Hoboken, John Wiley & Sons, 2004."},{"key":"2024102404131153000_32.168.230021.28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bimj.201700067","article-title":"Variable selection \u2013 a review and recommendations for the practicing statistician","volume":"60","author":"Heinze","year":"2018","journal-title":"Biom J"},{"key":"2024102404131153000_32.168.230021.29","doi-asserted-by":"crossref","unstructured":"Hosmer Jr DW , Lemeshow S , Sturdivant RX . Applied logistic regression. Hoboken, John Wiley & Sons, 2013.","DOI":"10.1002\/9781118548387"},{"key":"2024102404131153000_32.168.230021.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6460"},{"key":"2024102404131153000_32.168.230021.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.05.009"},{"key":"2024102404131153000_32.168.230021.32","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06295361"},{"key":"2024102404131153000_32.168.230021.33","doi-asserted-by":"publisher","DOI":"10.1186\/s41512-019-0064-7"},{"key":"2024102404131153000_32.168.230021.34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6"},{"key":"2024102404131153000_32.168.230021.35","doi-asserted-by":"crossref","first-page":"e1209","DOI":"10.1016\/S2214-109X(21)00306-5","article-title":"Validating novel diagnostic assays for tuberculosis in the context of existing tools","volume":"9","author":"Kerkhoff","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2024102404131153000_32.168.230021.36","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS) . 2020 Global AIDS update - Seizing the Moment - Tackling entrenched inequalities to end epidemics, Geneva, UNAIDS, 2020."},{"key":"2024102404131153000_32.168.230021.37","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000091"},{"key":"2024102404131153000_32.168.230021.38","doi-asserted-by":"crossref","first-page":"e907","DOI":"10.1016\/S2214-109X(16)30248-0","article-title":"Location, location, location: tuberculosis services in highest burden countries","volume":"4","author":"Huddart","year":"2016","journal-title":"Lancet Glob Health"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0021-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:05:56Z","timestamp":1740373556000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0021-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":38,"journal-issue":{"issue":"168","published-online":{"date-parts":[[2023,6,7]]},"published-print":{"date-parts":[[2023,6,30]]}},"alternative-id":["10.1183\/16000617.0021-2023"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0021-2023","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,7]]}}}